Chitosan Interferon-γ Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses

Chitosan Interferon-γ Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses

<p/> <p>The use of chitosan nanoparticles as carriers for expression plasmids represents a major improvement in gene expression technology. We demonstrated previously that treatment with chitosan interferon-γ (IFN-γ) plasmid deoxyribonucleic acid (DNA) nanoparticles (chitosan interferon-...

Full description

Bibliographic Details
Main Authors: Kong Xiaoyuan, Hellermann Gary R, Zhang Weidong, Jena Prasanna, Kumar Mukesh, Behera Aruna, Behera Sumita, Lockey Richard, Mohapatra Shyam S
Format: Article
Language:English
Published: BMC 2008-09-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
allergy
asthma
interferon
Online Access:http://www.aacijournal.com/content/4/3/95

Internet

http://www.aacijournal.com/content/4/3/95

Similar Items